Study of Tofacitinib in Refractory Dermatomyositis: An Open‐Label Pilot Study of Ten Patients is a research paper published in Arthritis & Rheumatology (2020). On theSindex it has a DataRank of 6.9. It has been cited 155 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.757
From this paper's citation signal
Citation Network Contribution
6.1
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Institutes of Health
Grant: 5 K23 NS091379
National Institutes of Health
Grant: P30‐AR070254
National Institutes of Health
Grant: R01GM129085
National Institutes of Health
Grant: 5R01GM129085-04
Computational Methods to Characterize Alternative Splicing from Massive Collections of RNA-seq Data
National Institutes of Health
Grant: 1P30AR070254-01
Johns Hopkins Rheumatic Diseases Resource-based Core Center
National Institutes of Health
Grant: 5K23NS091379-04
Magnetic resonance imaging and spectroscopy biomarkers for facioscapulohumeral muscular dystrophy
NINDS NIH HHS
Grant: K23 NS091379
NIAMS NIH HHS
Grant: P30 AR070254
NIH HHS
Grant: P30-AR070254
FWCI
12.74
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals